Latest News for: efficacy
Edit
D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types
PR Newswire 30 Apr 2026
Edit
RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease
PR Newswire 30 Apr 2026
Edit
RedHill’s RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn’s Disease (Form 6-K) (Redhill Biopharma Ltd)
Public Technologies 30 Apr 2026
Efficacy to RHB-104 - Important Step in RHB-204 ... Importantly, MAP killing efficacy was achieved with lower doses of two of the ... in Mycobacterium avium subspecies paratuberculosis (MAP) killing efficacy.
Edit
Norfolk Daily News
29 Apr 2026
Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" ...
WASHINGTON, April 28, 2026 ... .
Edit
Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence
PR Newswire 29 Apr 2026
VNDA) today announced the publication of the original research article titled "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in New England Journal of Medicine (NEJM) Evidence1.
Edit
Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence (Vanda Pharmaceuticals Inc)
Public Technologies 29 Apr 2026
Edit
Hastings Tribune
28 Apr 2026
Saving Limbs Where Others Stop: Cagent Vascular Announces Landmark Peer-Reviewed Data Demonstrating Safety and Efficacy ...
Edit
Saving Limbs Where Others Stop: Cagent Vascular Announces Landmark Peer-Reviewed Data Demonstrating Safety and Efficacy of ...
Business Wire 28 Apr 2026
Edit
ICYMI: Bennet Questioning Leads Kennedy to Acknowledge Safety and Efficacy of Measles Vaccine (Michael F Bennet)
Public Technologies 24 Apr 2026
). Apr 23, 2026 . Press Releases. Video of Bennet's Full Line of Questioning During the Hearing is Available HERE. Washington, D.C. - Colorado U.S. Senator Michael Bennet pressed U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr ... Collins.
Edit
New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures
PR Newswire 24 Apr 2026
BOSTON, April 24, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE ... A Single-Center Experience on Efficacy and Complications," was published earlier this week in the Journal of Cardiovascular Electrophysiology ... In March 2026, the U.S ... CT ... CT ... 21% ... .
Edit
Rapid City Journal
23 Apr 2026
Feds will not publish vaccine efficacy report
A report showing the efficacy of COVID-19 vaccines ...
Edit
Nectero Therapeutics Reports Two-Year Safety and Efficacy Data from First-in-Human Trial for Treatment of Small- ...
Nasdaq Globe Newswire 23 Apr 2026
The results were presented at Charing Cross 2026 by Dr ... .
Edit
US blocks COVID-19 vaccine efficacy report from CDC journal
Daily Sabah 22 Apr 2026
A report on the effectiveness of COVID-19 vaccines has been blocked from publication in the U.S. Centers for Disease Control and Prevention’s flagship scientific journal, a spokesp ....
Edit
Miv-cel (Mivocabtagene Autoleucel; KYV-101), CD19 CAR T-Cell Therapy Shows Efficacy and Safety in Stiff Person Syndrome in a Pivotal, Multicenter, Phase 2 Study (KYSA-8) (Kyverna Therapeutics Inc)
Public Technologies 22 Apr 2026
). The text version of this document is not available ... Attachments Permalink. Disclaimer.
- 1
- 2
- Next page »